Table 1 Summary of extracted articles
From: A scoping review of global COVID-19 vaccine hesitancy among pregnant persons
Study | Country | Study type | No. participants | Study timeline | Number (%) vaccine hesitant |
|---|---|---|---|---|---|
High Income Countries (HIC) | |||||
Davies et al.55 | England | Quantitative | 202 | October–November 2021 | 39 (33%) |
Rikard-Bell et al.17 | Australia | Quantitative | 287 | September 15–October 22, 2021 | 25% |
Geoghegan et al.24 | Ireland (HIC) | Mixed-Methods | 300 | December 4, 2020–January 14, 2021 | 108 (36%) |
Sutton et al.30 | USA (HIC) | Quantitative | 1012 | January 7–29, 2021 | 108 (50%) |
Battarbee et al.33 | USA (HIC) | Quantitative | 914 | August 9–December 10, 2020 | 429 (46.9%) |
Perrotta et al.48 | USA (HIC) | Quantitative | 299 | March 1–July 23, 2021 | 82 (27.4%) |
Schaal et al.46 | Germany (HIC) | Quantitative | 2339 | March 30–April 19, 2021 | 878 (86.3%) |
Reifferscheid et al.35 | Canada (HIC) | Quantitative | 193 | May 28–June 7, 2021 | 82 (42.6%) |
Husain et al.29 | UK (HIC) | Quantitative | 441 | September 1, 2021–February 28, 2022 | Not reported |
Citu et al.50 | Romania (HIC) | Quantitative | 345 | October 1–December 1, 2021 | 96 (52.2%) |
Razzaghi et al.40 | USA (HIC) | Quantitative | 1516 | March 31–April 16, 2021 | 54.30% |
Levy et al.14 | USA (HIC) | Quantitative | 662 | December 14, 2020–January 14, 2021 | 277 |
Simmons et al.51 | USA (HIC) | Quantitative | 387 | December 24, 2020–January 27, 2021 | 220 (57%) |
Mattocks et al.36 | USA (HIC) | Quantitative | 72 | January–May 2021 | 50 (69%) |
Ghamri et al.42 | Saudi Arabia (HIC) | quantitative | 5307 | July–September 2021 | 32% |
Hosokawa et al.53 | Japan (HIC) | Quantitative | 1621 | July 24–August 30, 2021 | 825 (50.9%) |
Citu et al.43 | Romania (HIC) | Quantitative | 345 | January 1–May 1, 2022 | Not reported |
Nowacka et al.28 | Poland (HIC) | Quantitative | 1033 | December 2021–February 2022 | 324 (31.4%) |
Egloff et al.22 | France (HIC) | Quantitative | 664 | February 18–April 5, 2021 | 468 (70.5%) |
Ward et al.34 | Australia (HIC) | Quantitative | 218 | September–October 2021 | 36 (29.5%) |
Tatarević et al.37 | Croatia (HIC) | Quantitative | 430 | May–October 2021 | 361 (84%) |
Colciago et al.25 | Italy (HIC) | Quantitative | 538 | February 1–March 3, 2022 | 17.30% |
DesJardin et al.44 | USA (HIC) | Quantitative | 157 | September–October 2021 | 97 (61.7%) |
Sutanto et al.23 | USA (HIC) | Quantitative | 109 | August 6–September 10, 2021 | 35 |
Redmond et al.45 | USA (HIC) | Mixed-Methods | 27 | June–August 2020 | Limited |
Huang et al.41 | USA (HIC) | Mixed-Methods | 1182 | January 1, 2020–April 28, 2021 | 28 (40.6%) |
Lis‐kuberka et al.57 | Poland (HIC) | Quantitative | 1196 | November 15–December 13, 2021 | 400 unvaccinated |
Middle Income Countries (MIC) | |||||
Ercan et al.20 | Turkey (MIC) | Quantitative | 250 | March–April 2021 | 183 (73.2%) |
GoncuAyhan et al.19 | Turkey (MIC) | Quantitative | 300 | January 1–February 1, 2021 | 189 (63%) |
Tao et al.38 | China (MIC) | Quantitative | 1392 | November 13–27, 2020 | 315 (22.6%) |
Abuhammad et al.54 | Jordan (MIC) | Quantitative | 414 | September–October 2021 | Not reported |
Pairat and Phaloprakarn26 | Thailand (MIC) | Quantitative | 171 | July 1–September 30, 2021 | 67 (39.2%) |
Ekmez and Ekmez56 | Turkey (MIC) | Quantitative | 471 | October 2020–March 2021 | Not reported |
Uludağ et al.39 | Turkey (MIC) | Qualitative | 16 | October 6–November 13, 2021 | 12 |
Qasrawi et al.21 | Palestine (MIC) | Quantitative | 728 | October–November 2021 | 577 (79.3%) |
Nguyen et al.27 | Vietnam (MIC) | Quantitative | 651 | January–February 2021 | 258 (39.6%) |
Low Income Countries (LIC) | |||||
Mose and Yeshaneh18 | Ethiopia (LIC) | Quantitative | 396 | January 1–30, 2021 | 116 (29.3%) |
Nemat et al.31 | Afghanistan (LIC) | Quantitative | 491 | July 10–20, 2021 | 449 (91.4%) |
Tefera and Assefaw15 | Ethiopia (LIC) | Mixed-Methods | 702 | January 1–30, 2022 | 77.40% |
Aynalem et al.16 | Ethiopia (LIC) | Mixed-Methods | 350 | September 1–October 30, 2021 | Not reported |
Kebede et al.49 | Ethiopia (LIC) | Quantitative | 336 | April 7–June 10, 2021 | 70 (20.1%) |
Mixed | |||||
Skjefte et al.47 | Multiple | Quantitative | 17,871 | October 28–November 18, 2020 | 48% |
Januszek et al.32 | Poland (HIC) and Ukraine (MIC) | Quantitative | 300 | June–August 2021 | 64.7% in Poland, 83.3% in Ukraine |
Naqvi et al.52 | Multiple | Quantitative | 13,105 | February–November 2021 | 8.50% |
